newsfilter
← Latest News
FDA Approved Drugs·

Approval of Briumvi, Bla #761238

Approval Date: 01/16/2026; Drug Name: Briumvi, Bla #761238; Active Ingredients: UBLITUXIMAB-XIIY; Company: Tg Therapeutics, Inc; Submission Status: Approval; Application Number: 761238

Company
TG THERAPEUTICS, INC
Keywords
TG THERAPEUTICS, INC